Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...

A large U.S. study finds that older breast cancer patients using estrogen creams experience longer survival rates and lower ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

When facing a cancer diagnosis, the usual treatment modalities are surgery, chemotherapy, or radiation therapy. But what if there was another powerful weapon in the fight against cancer you haven’t ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

In tests with mice, a protein derived from the virus boosted the immune system's ability to kill cancer cells.

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Combination treatment could also benefit patients with lung, bowel, pancreatic and other solid cancers who don’t respond to ...

Study examines treatment options for those with operable non-small cell lung cancer, the leading cause of cancer deaths ...

Bristol Myers Squibb and BioNTech to co-develop cancer immunotherapy BNT327 in a deal worth up to $11.1 billion.

Almost one in five patients with advanced melanoma survived for five years after receiving lifileucel, with tumours shrinking ...